Literature DB >> 29104143

Assessing antigen specific HLA-DR+ antibody secreting cell (DR+ASC) responses in whole blood in enteric infections using an ELISPOT technique.

Taufiqur Rahman Bhuiyan1, Mohammad Rubel Hoq2, Naoshin Sharmin Nishat2, Deena Al Mahbuba2, Rasheduzzaman Rashu2, Kamrul Islam2, Lazina Hossain2, Jason B Harris3, Edward T Ryan4, Stephen B Calderwood4, Ann-Mari Svennerholm5, Firdausi Qadri2.   

Abstract

Antibody secreting cells (ASCs) generate antibodies in an antigen-specific manner as part of the adaptive immune response to infections, and these cells increase their surface expression of HLA-DR. We have studied this parameter (HLA-DR+ ASC) in patients with recent diarrheal infection using immuno-magnetic cell sorting and an enzyme linked immunospot (ELISPOT) technique that requires only one milliliter of blood. We validated this approach in adult patients with cholera (n = 15) or ETEC diarrhea (n = 30) on days 2, 7 and 30 after showing clinical symptom at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) hospital in Dhaka, and we compared responses to age-matched healthy controls (n = 7). We found that HLA-DR+ ASC (DR+ASC) responses specific both for T cell-dependent (cholera toxin B subunit), and T cell-independent (lipopolysaccharide) antigens were elevated at day 7 after showing clinical cholera symptom. Similarly, DR+ASCs were elevated against both heat-labile toxin and colonization factors following ETEC infection. We observed significant correlations between antigen-specific DR+ASC responses and antigen-specific, gut homing ASC and plasma antibody responses. This study demonstrates that a simple ELISPOT procedure allows determination of antigen-specific ASC responses using a small volume of whole blood following diarrhea. This technique may be particularly useful in studying DR+ASC responses in young children and infants, either following infection or vaccination.
Copyright © 2017 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  ASCs; Cholera; ELISPOT; ETEC; HLA-DR+; Immune response

Mesh:

Substances:

Year:  2017        PMID: 29104143      PMCID: PMC6240134          DOI: 10.1016/j.micinf.2017.10.005

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  31 in total

1.  Mucosal immunologic responses in cholera patients in Bangladesh.

Authors:  Taher Uddin; Jason B Harris; Taufiqur Rahman Bhuiyan; Tahmina Shirin; Muhammad Ikhtear Uddin; Ashraful Islam Khan; Fahima Chowdhury; Regina C LaRocque; Nur Haque Alam; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

Review 2.  The generation of antibody-secreting plasma cells.

Authors:  Stephen L Nutt; Philip D Hodgkin; David M Tarlinton; Lynn M Corcoran
Journal:  Nat Rev Immunol       Date:  2015-02-20       Impact factor: 53.106

3.  Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood.

Authors:  Giulietta Saletti; Nicolas Çuburu; Jae Seung Yang; Ayan Dey; Cecil Czerkinsky
Journal:  Nat Protoc       Date:  2013-05-09       Impact factor: 13.491

4.  Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules.

Authors:  L A Matis; L H Glimcher; W E Paul; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

5.  Role of PCF8775 antigen and its coli surface subcomponents for colonization, disease, and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits.

Authors:  A M Svennerholm; Y L Vidal; J Holmgren; M M McConnell; B Rowe
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

6.  Monoclonal antibodies against enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) that cross-react immunologically with heterologous CFAs.

Authors:  A Rudin; M M McConnell; A M Svennerholm
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers.

Authors:  M Quiding-Järbrink; M Lakew; I Nordström; J Banchereau; E Butcher; J Holmgren; C Czerkinsky
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

8.  Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children.

Authors:  Firdausi Qadri; Firoz Ahmed; Tanvir Ahmed; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

9.  Evaluation of a typhoid/paratyphoid diagnostic assay (TPTest) detecting anti-Salmonella IgA in secretions of peripheral blood lymphocytes in patients in Dhaka, Bangladesh.

Authors:  Farhana Khanam; Alaullah Sheikh; Md Abu Sayeed; Md Saruar Bhuiyan; Feroza Kaneez Choudhury; Umme Salma; Shahnaz Pervin; Tania Sultana; Dilruba Ahmed; Doli Goswami; Md Lokman Hossain; K Z Mamun; Richelle C Charles; W Abdullah Brooks; Stephen B Calderwood; Alejandro Cravioto; Edward T Ryan; Firdausi Qadri
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

10.  Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses.

Authors:  Daniel T Leung; Taufiqur R Bhuiyan; Naoshin S Nishat; Mohammad Rubel Hoq; Amena Aktar; M Arifur Rahman; Taher Uddin; Ashraful I Khan; Fahima Chowdhury; Richelle C Charles; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.